Statement Of Cash Flows [Abstract]

BioGaia - Filing #679336

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations	4 66 90 6 SEK	—	—	376 246 SEK	—
Interest paid, classified as operating activities	7 89 SEK	—	—	5 386 SEK	—
Interest received, classified as operating activities	41 250 SEK	—	—	7 634 SEK	—
Income taxes paid (refund), classified as operating activities	80 294 SEK	—	—	54 910 SEK	—
Cash flows from (used in) operating activities	425 965 SEK	—	—	3 18 94 3 SEK	—
Cash flows from (used in) investing activities [abstract]
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities	2 221 SEK	—	—	- SEK	—
Purchase of property, plant and equipment, classified as investing activities	4 8 56 8 SEK	—	—	1 7 91 6 SEK	—
Purchase of intangible assets, classified as investing activities	1 46 SEK	—	—	22 5 SEK	—
Cash flows from (used in) investing activities	50 935 SEK	—	—	18 141 SEK	—
Cash flows from (used in) financing activities [abstract]
Payments of other equity instruments	417,000 SEK	—	—	2 14 SEK	—
Payments of lease liabilities, classified as financing activities	10 755 SEK	—	—	9 143 SEK	—
Dividends paid, classified as financing activities	29 2 84 9 SEK	—	—	30 1 33 1 SEK	—
Other inflows (outflows) of cash, classified as financing activities	4 400 SEK	—	—	2 90 0 SEK	—
Cash flows from (used in) financing activities	30 8 42 1 SEK	—	—	3 13 5 88 SEK	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	66 609 SEK	—	—	12 786 SEK	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	10 783 SEK	—	—	16 472 SEK	—
Cash and cash equivalents	—	1 544 192 SEK	1 488 366 SEK	—	1 484 680 SEK